Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial

NCT04403282 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

9

Enrollment

FED

Sponsor class

Stopped Vaniqa no longer manufactured

Conditions

Pseudofolliculitis Barbae

Interventions

DRUG: Eflornithine Topical
DRUG: Placebo Eflornithine Topical

Sponsor

Walter Reed National Military Medical Center